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Abstract
The Bifibobacterium longum subsp. longum 35624TM strain (formerly named Bifidobacter-
ium longum subsp. infantis) is a well described probiotic with clinical efficacy in Irritable
Bowel Syndrome clinical trials and induces immunoregulatory effects in mice and in
humans. This paper presents (a) the genome sequence of the organism allowing the
assignment to its correct subspeciation longum; (b) a comparative genome assessment
with other B. longum strains and (c) the molecular structure of the 35624 exopolysacchar-
ide (EPS624). Comparative genome analysis of the 35624 strain with other B. longum
strains determined that the sub-speciation of the strain is longum and revealed the pres-
ence of a 35624-specific gene cluster, predicted to encode the biosynthetic machinery for
EPS624. Following isolation and acid treatment of the EPS, its chemical structure was deter-
mined using gas and liquid chromatography for sugar constituent and linkage analysis,
electrospray and matrix assisted laser desorption ionization mass spectrometry for
sequencing and NMR. The EPS consists of a branched hexasaccharide repeating unit con-
taining two galactose and two glucose moieties, galacturonic acid and the unusual sugar 6-
deoxy-L-talose. These data demonstrate that the B. longum 35624 strain has specific
genetic features, one of which leads to the generation of a characteristic
exopolysaccharide.
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Introduction
The gut microbiome contributes to host health by multiple mechanisms, including digestion,
competitive exclusion of pathogens, degradation of mucins, enhancement of epithelial cell dif-
ferentiation and promotion of mucosa-associated lymphoid tissue proliferation [1, 2]. Further-
more, accumulating evidence suggests that the composition and metabolic activity of the gut
microbiome has profound effects on proinflammatory activity and the induction of immune
tolerance within mucosal tissue [3–6]. Certainmicrobes induce regulatory responses, while
others induce effector responses, resulting in the case of healthy individuals in a balanced
homeostatic immunological state, which protects against infection and controls aberrant, tis-
sue-damaging inflammatory responses [7].
The Bifidobacterium longum subsp. longum 35624TM strain (formerly named B. longum
subsp. infantis) is known to induce tolerogenic responses within the gut and reduces disease
symptoms in irritable bowel syndrome patients [8–10]. Induction of T regulatory cells by B.
longum 35624 strain (35624) in mice is associated with protection against colitis, arthritis,
allergic responses and pathogen-induced inflammation [11–15]. Administration of this bacte-
rium to humans increases Foxp3+ lymphocytes in peripheral blood, enhances IL-10 secretion
ex vivo, and reduces the level of circulating proinflammatory biomarkers in a wide range of
patient groups and healthy volunteers [16, 17]. A number of host mechanisms have been
described,which contribute to the anti-inflammatory activity of this microbe, including TLR-2
and DC-SIGN recognition, and retinoic acid release by dendritic cells [16, 18].
Bifidobacterial strain-specific structures that interact with the host are recently being better
described and bifidobacterial-associatedexopolysaccharides (EPS) are of particular interest in
the field. The genetic content and structure of bifidobacterialEPS clusters has already been
described as being highly variable [19]. A number of in vitro studies have demonstrated how
EPS frommembers of several bifidobacterial species elicit different imunological responses
[20]. For example, an in vivo study of EPS produced by Bifidobacterium breveUCC2003
showed how it promotes persistence in the gut following colonization through evasion of the
adaptive host immune response [21].
In this study we wished to identify and characterize 35624 strain-specific features, such as
the 35624 EPS.We sequenced the genome of 35624 and following core genome-based compar-
isons to related bifidobacterial strains, 35624 was shown to clearly belong to the B. longum
subsp. longum phylogenetic group. Furthermore, a 35624-specific gene cluster, designated
eps624, predicted to be responsible for the production of a exopolysaccharide (EPS624), was
identified. Following detailed chemical analysis, we identified that EPS624 contained a branched
hexasaccharide repeating unit with two galactoses, two glucoses, galacturonic acid and the
unusual sugar 6-deoxytalose.
Results
35624 genome sequencing and comparison to other sequenced B.
longum genomes
The complete genome sequence of the 35624 strain was determined to be 2.26 Mb in size with
a G+C% content of 59.34% (for salient features of this genome see Table 1; S1 Fig), consistent
with values reported for other bifidobacterial genomes [22]. A total of 1,735 open reading
frames (ORFs) were identified, and of these a function could be assigned to 1,370 based on sim-
ilarity searches to public data bases. In order to accurately evaluate 35624’s phylogeny and
(sub)species assignment, a B. longum phylogenetic supertree was constructed based on the
deduced protein sequences of the B. longum core-genome [23]. From the resulting supertree,
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two major clades were identified (Fig 1), of which the largest encompasses twenty six strains of
the B. longum subsp. longum phylogenetic group, including the type strain of this subspecies
[23]. 35624 had, similar to strains B. longum 157F and B. longum CCUG52486, originally been
classified as a subspecies infantis member. However, classification as based on the phylogenetic
supertree approach clearly shows that these three strains are positionedwithin the B. longum
subsp. longum phylogenetic group, and therefore represent bona fidemembers of the subspe-
cies longum, their original miss-assignment being due to the sole use of (partial) 16S rRNA-
based taxonomic classification [23].
Exploration of the 35624 genome revealed the presence of homologs of the tad locus which
is known to be responsible for the biosynthesis of Type IVb pili, required for host colonisation
[24]. Interestingly, 35624 is not predicted to encode so-called sortase-dependentpili, which
have previously been shown to play a role in host-microbe interactions [25]. Comparative anal-
ysis was performed between the 35624 genome and other B. longum genome sequences in the
hope to locate genetic elements specifying other extracellular structures that may be involved
in such interactions and that would exhibit 35624-specific attributes. The main genomic differ-
ence between 35624 and other B. longum genomes is the presence of a 26.2 Kb gene cluster,
designated here as eps624 (Fig 2), predicted to encode the biosynthetic machinery for EPS bio-
synthesis. Comparative analysis of complete and publicly available B. longum subsp. longum
genomes shows that a predicted EPS-specifyinggene cluster is present in the same location in
other B. longum subs. longum genomes, but that the genetic composition of these gene clusters
is very diverse at intraspecies level and that the eps624 gene cluster only displays partial similar-
ity to three other EPS-specifyinggene clusters (Fig 2). This analysis furthermore reveals that
some of these EPS gene clusters lack certain critical functions required for EPS synthesis (Fig
2). For example, the EPS cluster in B. longum subsp. longum JCM1217 appears to lack a flip-
pase-encoding gene which is responsible for the export of EPS precursors across the cell mem-
brane. These findings are in agreement with a recent study [23].
Notably, the eps624 cluster encodes a number of key enzymes that are predicted to be
required for EPS production by means of the so-calledWzx/Wzy-dependent pathway, which
typically employs a priming glycosyltransferase (pGT), one or more glycosyl transferases
(GHs), a flippase, and a polymerase to produce an extracellular heteropolysaccharide [19, 26].
The first gene (corresponding to locus tag BL_0342 and designated here as pgt624) of the eps624
gene cluster is predicted to encode the pGT, which adds the first monosaccharide to a cyto-
plasmic, membrane-bound carriermolecule undecaprenyl as part of the oligosaccharide
Table 1. Bifidobacterium longum general genome features.
B. longum subsp.
longum NCIMB 8809
B. longum subsp.
longum CCUG 30698
B. longum
35624
B. longum subsp.
longum NCC2705
B. longum subsp.
longum DJO10A
Isolated from Nursling stool Human adult intestine Human adult
intestine
Infant faeces Young adult faeces
Genome Size 2.34 2.45 2.26 2.25 2.37
G+C content % 60.1 60.22 59.34 60.12 60.15
Number of identified genes 1872 1983 1735 1727 1990
Percentage of genes
functionally assigned
77% 74% 79% 79% 76%
Prophage 1 (complete) 1 0 1 1
Episome 1 0 1 1 1
rRNA copies 3 2 4 4 4
tRNA copies 56 70 56 57 58
CRISPR 0 0 1 1 1
doi:10.1371/journal.pone.0162983.t001
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subunit biosynthesis [27]. The eps624 cluster encodes five additional GTs (corresponding to
locus tags BL_0345, BL_0346, BL_0349 and BL_0352; Fig 2), which are predicted to each add
one monosaccharide to the carriermolecule so as to complete the oligosaccharide subunit,
prior to its export to the external side of the membrane by a flippase (predicted to be encoded
by a gene corresponding to locus tag BL_0355) and its subsequent use by a polymerase (puta-
tively specified by locus tag BL_0353) to produce the EPS polymer. Interestingly, two adjacent
genes of the eps624 cluster, corresponding to B624_0347 and B624_0348, are predicted to
encode a UDP-glucuronate 5'-epimerase and a UDP-glucose 6-dehydrogenase, suggesting that
one of the incorporatedmonosaccharides of the EPS is an epimer of glucuronic acid, e.g.
galacturonic acid or mannuronic acid. Three genes located within the eps624 cluster, corre-
sponding to locus tags B624_0360 through to B624_0362 (Fig 2), encode enzymes known to be
Fig 1. Phylogenetic tree based on the B. longum core-genome. (A) The B. longum subsp. longum
phylogenetic group. (B) The B. longum subsp. infantis phylogenetic group. B. longum subsp. longum and B.
longum subsp. infantis type strains are indicated in blue text. Lactobacillus salivarius was included as an outlier.
doi:10.1371/journal.pone.0162983.g001
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involved in the biosynthesis of dTDP-L-rhamnose [19, 28, 29], while the deduced protein
products of B624_0350 and B624_0357 are predicted to encodeNAD-dependent reductase/
epimerase enzymes. Such enzymes have been shown to be involved in the rerouting of the
dTDP-L-rhamnose biosynthesis pathway towards the production of dTDP-D-fucose or dTDP-
6-deoxy-L-talose [30–32]. The eps624 cluster also encodes two predicted acetyl transferases,
similar to enzymes that have previously been shown to performO-acetylation reactions on par-
ticular sugar components (such as 6-deoxy-L-talose) in polysaccharides [33]. Furthermore, the
genes with locus tags B624_0344 and B624_0366 represent putative tyrosine kinase and phos-
photyrosine protein phosphatase activities, respectively, which have been associated with
Fig 2. EPS gene cluster. Illustration of the EPS cluster located in the B. longum 35624 genome and comparison to similar
clusters located in B. longum 105-A, B. longum subsp. longum JCM1217 and B. longum subsp. longum NCC2705. Each
gene is colour-coded according to function which is indicated in the legend located at the end of the page. Percentages
represent the percent of sequence similarity at the protein level with corresponding genes in the B. longum 35624 genome.
The locus tags of the first and last genes located in the EPS clusters of B. longum 105-A, B. longum subsp. longum JCM1217
and B. longum subsp. longum NCC2705 are also indicated in the illustration.
doi:10.1371/journal.pone.0162983.g002
Bifidobacterial Polysaccharide
PLOS ONE | DOI:10.1371/journal.pone.0162983 September 22, 2016 5 / 23
controlling EPS export, polymerisation and production [34, 35]. Therefore, based on the gene
content of the eps624 cluster, we predict that the EPS produced by the 35624 strain is composed
of a repeating subunit that consists of six monosaccharides, of which one is an epimer of glucu-
ronic acid, one or two others are either D-fucose or 6-deoxy-talose, and some of which may be
O-acetylated.We show below that this prediction is quite correct.
35624 EPS isolation
We performed electronmicroscopy analysis, which indeed revealed the presence of a thick EPS
layer on the cell surface of the 35624 strain (Fig 3A). Following harvesting of 35624 cells,
which were grown on agar plates to minimize carryover of media components, an EPS solution
was generated by agitating the cells in PBS. The harvested EPS solution was mixed with ethanol
and the EPS aggregated at the center of the surface of the ethanol solution, which facilitated
harvesting of the EPS without the need for centrifugation. The EPS aggregations were taken
with a spatula, resuspended in water and dialysed against water to remove contaminants and
residual ethanol. Further purification using reverse phase columns resulted in a highly purified
polysaccharide, with no detectable proteins or lipids remaining. The precipitated and purified
EPS is illustrated in Fig 3B.
35624 EPS chemical characterization
Comparison of the purified 35624 EPS with dextran standards by high performance size exclu-
sion chromatography (SEC) indicated an average mass in excess of 1 MDa (Mw) (Fig 4A).
Monosaccharide analysis of SEC fractions gave the same composition for all fractions of the
broad peak. Anion exchange of the EPS revealed it as being negatively charged. 1H NMR data
recorded at 90°C in D2O showed severe line broadening (data not shown) but nevertheless
indicated the presence of methyl groups corresponding to acetyl and 6-deoxy protons in an
approximate 1:1 ratio.
Analysis of the EPS hydrolysates was accomplished by high performance liquid chromatog-
raphy (HPLC) of sugars derivatizedwith either 1-phenyl-3-methyl-5-pyrazolone (PMP) or
anthranilic acid using at first the standard solvent systems. This implied the occurrence of glu-
cose (Glc), galactose (Gal) and a small amount of galacturonic acid (GalA) besides two peaks
not coeluting with any standard (Fig 4B). Anthranilic acid derivatives were then analyzed with
a volatile buffer allowingmass spectrometryof isolated peaks, which revealed one unknown
peak as being a disaccharide consisting of uronic acid and a hexose and the other one as a
deoxy-hexose that neither was fucose, rhamnose or quinovose (6-deoxyglucose).Gas
Fig 3. B. longum 35624 electron microscopy. (A) A layer of extracellular polysaccharide is clearly visible by electronic
microscopy of the 35624 strain. (B) The isolated and purified EPS is illustrated.
doi:10.1371/journal.pone.0162983.g003
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chromatography-mass spectrometry (GC-MS) of partiallymethylated alditol acetates identi-
fied it as 6-deoxy-hexose (data not shown). With NMR data pointing at 6-deoxy-talose
(6dTal), this rare sugar was synthetized from L-fucose by epimerization at C-2 and deoxy-hex-
ose indeed co-eluted with 6dTal (Fig 4B). Adding the peak area of the aldobiuronic acid to that
of Gal and GalA, the molar ratio of the constituent sugars Glc, Gal, GalA and a 6dTal approxi-
mated 2: 2: 1: 1 respectively.
The products of mild acid treatment were analysed by porous graphitic-liquid chromatogra-
phy-electrospray ionization-mass spectrometry (PGC-LC-ESI-MS). The occurence of several
Fig 4. B. longum 35624 EPS characterization. (A) Comparison of the EPS (solid line) with a dextran standards dotted line)
demonstrated that EPS had an average molecular mass much higher than 1 MDa (Mw). (B) HPLC analysis of anthranilic acid-
labeled monosaccharides of EPS revealed the presence of glucose (Glc), galactose (Gal), some galacturonic acid (GalA) and two
additional peaks with masses corresponding to an aldobiuronic acid and a deoxy-hexose later identified as 6-deoxy-talose. The
upper trace in (B) is the standard mixture and the lower trace shows the results of the EPS sample. Numbers in the lower trace give
the masses of the compounds as determined by off-line ESI-MS.
doi:10.1371/journal.pone.0162983.g004
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isobaric fragments indicated lack of a preferred cleavage site. The smallest of the major frag-
ments was the tetrasaccharide os211 consisting of 2 Hex, 1 GalA and 1 dHex residue. ESI-MS/
MS of the BD4-reduced oligosaccharide identified its reducing end as hexose. Os211 was pres-
ent as a single isomer, which allowed the preparative isolation of os211 by hydrophilic interac-
tion HPLC for NMR analysis. The os311 and os411 fragments, when analyzed by PGC-LC-
ESI-MS/MS turned out to contain at least 3 isomers with hexose and 1 with deoxyhexose at the
reducing end (Fig 5A). Reducing end dHex on os411 and larger fragments implies this sugar to
be part of the main chain rather than a side arm. These isomers were isolated by preparative
PGC for MS/MS in permethylated form.
Fig 5. Mild acid hydrolysis of EPS. (A) Separation of EPS fragments by PGC HPLC with MS/MS detection. The extracted ion
chromatogram for mass 1008.39 Da shows four peaks. Their reducing end sugar was clearly revealed by ESI-MS/MS. Their
assignment as either Gal or Glc and the interpretation in terms of fragment structures was done a posteriori based on
MALDI-TOF data and on knowledge of the EPS structure. (B) Example of a MALDI-TOF/TOF fragment spectrum showing b-
ions from the non-reducing and y- and y´ (= 1,5x) -ions from the reducing end.
doi:10.1371/journal.pone.0162983.g005
Bifidobacterial Polysaccharide
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35624 EPS linkage analysis
Permethylation of the intact polysaccharide failed due its insolubility in DMSO. Results were
obtained upon gentle hydrolysis with 50 mMTFA (4 h 80°C). Peaks for a 4-substituted
6-deoxy-hexopyranose (or a 5-substituted furanose), terminal Glc, 4-substituted Gal and
2,4-disubstituted Gal were obtained in a ratio of approximately 0.8: 1: 0.6: 1: 1. A uronic acid
cannot be seen by this approach. Taking into account the incomplete hydrolysis of the uronic
acid´s glycosidic linkage as its acid function is regained during the hydrolysis step and the
higher volatility of dHex, this insinuates that each linkage variants occurs just once in the
repeating unit. The low yield of 4-substituted Gal pointed at its substitution by uronic acid,
which results in a particularily acid stable linkage.
Permethylation linkage analysis of fragment os211 revealed terminal Glc, 4-substituted
6-deoxy-hexose and a 4-substituted Gal at the reducing end. The occurrence of two singly
substituted and one terminal residue necessitates a linear topology of os211. As the occurrence
of aldobiuronic acid implies a HexA-Hex sequence, the only topology of os211 consistent with
the hitherto findings is Glc-d6Tal-GalA-Gal.
The chromatographically separated, reduced and perdeuteromethylated EPS fragments
were analyzed by MS/MS on a MALDI-TOF/TOF instrument (Fig 5B). The single os211 frag-
ment gave one y and one b fragment, that underpinned the Glc-dHex-GalA-Gal topology. In
the spectra of os311a and os411a, y-fragments with two and three hexoses and with three hex-
oses plus uronic acid were found. Necessarily, these y-fragments must have harbored the
branching Gal residue bearing the unsubstituted Glc residue. The topologyGalA-(Glc-)Gal-
Gal, however, could not lead to a fragment of m/z 503.3, with only one fragmentation char.
Rather, the MS/MS spectra for os311a and os411a could be reconciledwith the fragment struc-
ture GalA-Gal-(Glc-)Gal. Os311a did not show a b-fragment from the non-reducing terminus
but os411a presented the disaccharideHex-dHex (= Glc-dTal). Thus, together with the insights
from linkage analysis of os211, os311a could be assigned the sequence d6Tal-GalA-Gal-(Glc-)
Gal and os411a Glc-d6Tal-GalA-Gal-(Glc-)Gal, which is the hexasaccharide proposed to con-
stitute the repeating unit of 35624 EPS and which would also be fully consistent with the
genetic content of the eps624 cluster (see above).
The 600 MHz 1H-NMR spectra of verymild (as for permethylation) acid-treated exopoly-
saccharide sample were recorded in D2O at 297 K and 338 K, respectively. Since the latter con-
dition led to better resolved signals, the ensuing 13C NMR as well as COSY, TOCSY,
HSQC-TOCSY, HMBC and ROESY spectra were recorded at 338 K throughout. The proton
spectrum(Fig 6A) revealed inter alia six signals of equal intensity attributable to anomeric pro-
tons, which gave HSQC-correlations to connected carbons in the range of 97–104 ppm. The
absence of anomeric carbon signals shifted to lower-field than 104 ppm and of any signals of
non-anomeric carbons at a field lower than 82 ppm confirmed that furanose forms were not
present [36]. Five of the anomeric signals (B1-F1) had small homonuclear nuclear coupling
constants, while residue A displayed a larger coupling constant J1,2 (~ 8 Hz). The assignment of
the α-anomeric configuration for pyranose residues B-F was confirmed by the values of the
heteronuclear coupling constant JC-1,H-1 (observed in an HMBC experiment) that were found
in a range of 170–176 Hz. The coupling constant JC-1,H-1 for residueA was consistent with the
β-anomeric configuration (167.9 Hz). In the high-field segment of the 1H-NMR spectruma
methyl group signal being characteristic of a 6-deoxy-pyranose was found at 1.22 ppm.
In the low-field section of the spectrum, two additional, non-anomeric and spin-coupled
proton signals were seen (C4,C5). The signal observed at 4.62 ppm (C5) revealed an HMBC
connectivity to a carbon signal at 175.3 ppm, thus indicating the presence of a pyranosyluronic
acid (C).
Bifidobacterial Polysaccharide
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The presence of a hexasaccharide repeat unit was confirmed by analysis of the 150 MHz 13C
NMR spectrumwhich contained four signals of anomeric carbons in the region of 100–
104 ppm (A-D), and a slightly high-field shifted signal of double intensity at 97.5 ppm (E,F)
(Fig 6B). Pyranose ring carbon signals were present in the range between 65.9 and 81.5 ppm,
while methylene carbons (identified via an APT experiment) were shown as two broadened
singlets of double intensity at 61.6 and 60.9 ppm, respectively. Additionally, a carbonyl signal
originating from the uronic acid moiety was observed at 175.3 ppm, as well as the carbon signal
of the methyl group of the 6-deoxy sugar at 16.4 ppm.
Fig 6. B. longum 35624 EPS characterization. (A) The 600 MHz 1H NMR proton spectrum of the acid-treated
35624 EPS (D2O, 338 K) is illustrated. A part of the high-field region is displayed in the insert. (B) Expansion plot
of the 150 MHz 13C NMR spectrum of the acid-treated 35624 exopolysaccharide. The anomeric signals on the
left confirmed the presence of a hexasaccharide repeat unit.
doi:10.1371/journal.pone.0162983.g006
Bifidobacterial Polysaccharide
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Proton and carbon signals were then assigned using COSY, TOCSY, HSQC,HSQC-TOCSY
(Fig 7A and 7B), HMBC and ROESY experiments (Table 2). Glycosylation shifts were seen for
unitsA-E, whereas residue F occurred as an unsubstituted sugar. Glycosylation sites were iden-
tified at position 4 of residuesA-E. Residue E was found to be additionally substituted at car-
bon 2, based on an HMBC correlation from H-1 of F to C-2 of E. Furthermore, both anomeric
protons of residues E and F gave inter-residue ROEs in support of a close spatial proximity.
The observed substitution pattern was thus in full agreement with the results of the permethy-
lation analysis.
The absolute configuration of constituent sugars was derived from the analysis of the tri-
methylsilylated L-cysteinemethyl ester [37] and the results of the monosaccharide composition
analysis, this led to the assignment of a D-gluco configuration for residuesA and F and a D-
galacto configuration for residues C,D and E, respectively.
Key assignments were then obtained and confirmed from the tetrasaccharide fragment
os211 generated by acid treatment (0.25 M TFA, for 3 h at 80°C) of the EPS followed by boro-
hydride reduction and chromatographic purification.While data of the reduced hexitol com-
ponent could not be extracted due to significant signal overlap, the proton signals of three
pyranose unitsA, B, C could be fully assigned based on COSY and TOCSY experiments. This
allowed to identify the configuration of the constituent sugars based on homonuclear JH,H cou-
pling constants as well as 1H chemical shift information (Table 2). ResidueA was assigned as a
β-glucopyranosyl residue as seen from the J2,3 and J3,4 coupling constants being consistent with
a trans-diaxial arrangement of the respective protons. Signals arising from residues B and C
were close to those observed for the related units in the polysaccharide chain, whereas H-3 and
H-4 signals of unit A were shifted to higher field, indicating that hydrolysis had occurred at the
residue preceding unitA. The small values of the coupling constants J1,2, J3,4 and J4,5 in con-
junction with the large values seen for J2,3, identified residueC as α-galacturonic acid, whereas
residue B corresponds to an α-anomeric 6-deoxy-sugar. The coupling constants for the low-
field shifted H-5 and H-3 protons of residue B revealed small values for J4,5, J3,4 and J2,3, respec-
tively, which are compatible with the configuration of a 6-deoxy-talose or a 6-deoxy-gulose.
The absolute configuration of the 6-deoxy-sugar was eventually based on the molar rotation
values calculated for the polysaccharide. Published optical rotation values of methyl glycosides
were used for the calculation [38]. For a hexasaccharide repeat unit containing an α- and β-D-
glucopyranosyl unit, two α-D-galactopyranosyl units, one α-D-galactopyranosyluronic residue
and a 6-deoxy-α-talopyranose unit, the calculatedmolar rotation [MD] gives 1221.5 for
6-deoxy-α-D-talose as constituent sugar and 844.3 for the presence of 6-deoxy-α-L-talose,
which would correspond to optical rotation values of +126 and +87, respectively. The mea-
sured optical rotation value [α]D20 +84.7 (c 0.96, H2O) was in full agreement with the presence
of a 6d-L-talopyranose. This assignment was further supported by characteristic chemical shift
differences observed for anomeric carbons when engaged in linkages between L,D- and D,D-
configured sugars [39, 40]. The presence of rhamnose, fucose and 6-deoxy-quinovose was
excluded based on the results of the HPLCmonosaccharide analysis, while the 13C NMR chem-
ical shifts observed for residue B were not compatible with the presence of a 6-deoxy-gulose,
6-deoxy-altrose and 6-deoxy-allose [39]. The NMR data of the 6-deoxy-pyranose showed a
diagnostic high-field shifted 13C NMR signal as seen for C-3 of talose1 and were also in good
agreement with published NMR features of a disaccharide fragment β-D-Glcp-(1!4)-α-L-
6dTalp occurring in Burkholderia caribensis strain MWAP71 [41]. The identity of the deoxy-
sugar was eventually proven using a synthetic sample of L-6dTal.
HMBC data (two experiments with values of JCH-coupling constants of 5 and 11 Hz, respec-
tively, were performed) confirmed the assignment of spin systems with characteristic intraresi-
due correlations between the anomeric protons of residues C and F to carbon 3, and anomeric
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Fig 7. B. longum 35624 EPS proton and carbon signals. (A) A selected region of the multiplicity-edited,
gradient enhanced 1H, 13C-HSQC NMR spectrum of the exopolysaccharide. Letters denote the residues as
given in the structural formula and arabic numerals denote the respective pyranose position. Resonances
from anomeric carbons/protons, glycosylation sites and resolved signals are annotated. (B) Selected region
of the 1H, 13C-HSQC-TOCSY NMR spectrum (600 MHz) of the acid-treated 35624 EPS. Arabic numerals
before and after oblique stroke denote carbons and protons, respectively.
doi:10.1371/journal.pone.0162983.g007
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protons of residuesA, B and E to carbon 5, respectively. In addition the following inter-residue
connections were observed:H-1 of A and C-4 of B, H-1 of B and C-4 of C, H-4 of E and C-1 of
D, H-1 of F and C-2 of E.
Based on the combined evidence of sugar analysis, methylation data and NMR-data, the
35624 EPS structure is illustrated in Fig 8.
Discussion
Bifidobacteria comprise a significant proportion of the gut microbiota, in particular in infants,
and many strains are used as probiotics. Strain-specific beneficial effects are well established
and the genetic or structural differences that associate with such bifidobacterial strains are
beginning to emerge. In this report, we describe a 35624-specific gene cluster, responsible for
the production of a cell surface-associated exopolysaccharide (EPS). The 35624 EPS consists of
a branched hexasaccharide repeating unit with two galactoses, two glucoses, galacturonic acid
and the infrequent sugar 6-deoxytalose.
Bifidobacterial cell surface-associatedpolysaccharides have previously been proposed to (i)
mediate some of their health benefits, (ii) to aid in their tolerance to the harsh conditions
within the gut, and (iii) to influence composition of the gut microbiome by being used as a
growth substrate by other microbes [21, 27, 42, 43]. In general, bacterial EPS consists of repeat-
ing mono- or oligosaccharide subunits connected by varying glycosidic linkages, which are
structurally diverse. As previously reported, and as indicated in our genome comparisons, the
identified genes associated with the EPS biosynthetic machinery are highly diverse among the
analyzed bifidobacteria, likely contributing to strain-specific traits due to the expected
Table 2. 1H and 13C NMR chemical shifts (δ, ppm) of the exopolysaccharide (recorded at 338 K) and the tetrasaccharide os211 (recorded at 300 K)
from B. longum 35624.
Sugar residue H-1 H-2 H-3 H-4 H-5 H-6 (6a,6b)
C-1 C-2 C-3 C-4 C-5 C-6
!4)-β-D-Glcp-(1! 4.35 3.36 3.68 3.70 3.51 3.70, 3.84
A 103.83 74.36a 75.46b 76.90 75.76b 61.62
!4)-α-L-6-deoxy-Talp-(1! 5.25 3.80 3.88 3.86 4.06 1.22
B 102.10 70.49c 65.93 81.50 67.74 16.38
!4)-α-D-GalpA-(1! 4.96 3.87 4.00 4.38 4.62 -
C 100.69 69.66 71.34 77.33 72.84 175.26
!4)-α-D-Galp-(1! 4.94 3.80 3.88 4.06 4.30 3.73
D 101.16 69.31 70.43c 78.63 72.22d 60.89
!2,4)-α-D-Galp-(1! 5.66 3.97 3.98 4.08 3.96 3.78
E 97.47 74.22a 68.16 79.19 72.02d 60.89
α-D-Glcp-(1! 5.13 3.54 3.71 3.38 3.90 3.71
F 97.47 72.54 73.74 70.80 72.80 61.62
Tetrasaccharide os211 H-1 H-2 H-3 H-4 H-5 H-6 (6a,6b)
J (Hz) J (Hz) J (Hz) J (Hz) J (Hz) J (Hz)
!4)-β-D-Glcp-(1! 4.385 3.35 3.46 3.39 3.40 3.71, ~3.86
A 7.9 8.8 9.0 4.9, 12.5
!4)-α-L-6-deoxy Talp-(1! 5.275 3.84 3.915 n.d. 4.08 1.25
B 2.3 3.3 2.4 6.6
!4)-α-D-GalpA-(1!hexitol) 5.07 3.90 4.04 4.38 4.32 -
C 3.8 10.2 2.5 1.9 n.d.
a,b,c,d assignments may be reversed
doi:10.1371/journal.pone.0162983.t002
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structural and therefore functional diversity of such EPS molecules [19]. Of note, pathogen-
associated EPSs have long been known to be critical in host–microbe interactions, where they
facilitate adherence and colonization within the human host, with additional immunomodula-
tory effects [19, 44, 45]. Regarding the role of EPS in counteracting pathogens, a role of scaven-
ger and trapping system to recruit and present pathogens to host cell receptors has been
proposed [46]. With respect to gastrointestinal infections, the EPS produced by B. longum
BCRC 1464 has been shown to possess antimicrobial activity against pathogens and immune-
modulating activity, which causes release of the anti-inflammatory cytokine IL-10 [47]. Fur-
thermore, EPS of B. animalis subsp. lactis has been shown to act as an adherent surface trap-
ping pathogens on the mucus layer [46] and exopolysaccharide capsule production by a B.
breve strain was also shown to be linked to the evasion of adaptive B-cell responses [21].
Previously, the 35624 strain has been described as B. longum subsp. infantis according to
the most up to date information available at that time for classifying bifidobacteria subspecies.
However, following the full sequencing of the bacterial genome and the use of its core genome
for phylogenetic taxon assignment, it is now apparent that this bacterium should be reclassified
Fig 8. B. longum 35624 EPS composition and structure. The structure is annotated as the chemical formula and in
condensed form. Capital letters denote the residues as in Figs 6 and 7.
doi:10.1371/journal.pone.0162983.g008
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as B. longum subsp. longum. Clearly, the reclassification of the strain does not affect the strain-
specific beneficial effects previously described for 35624. However, very few probiotic strains
that are commercially available have been characterized to the same extent in terms of mecha-
nism and genome identification as the 35624 strain and it is likely that without such in-depth
analysis many probiotic products have been incorrectly classified and labeled. Lack of clarity
on the key mechanism of action associated with other probiotic products is compounded by
the fact that many contain multiple strains with unknown interactions.
Polysaccharides from B. bifidum, B. breve, B. infantis and B. longum strains typically contain
glucose and galactose, with rhamnose occasionally being described [48, 49]. The presence of
6-deoxy-L-talose in bifidobacterial polysaccharides has only been previously observedonce in
a B. adolescentis strain [50]. However, the repeating unit describedherein for the 35624 strain
has never been previously described in bifidobacteria.The occurrence of 6-deoxy-L-talose has
been previously described in unrelated microbial species, which includeAgrobacterium rubi,
Rhizobium loti, Treponema pectinovorum, Burkholderia pseudomallei,Mycobacterium intracel-
lulare,Mycobacterium smegmatis, Aeromonas hydrophila, Pseudoalteromonas flavipulchra,
Hafnia alvei, Actinobacillus actinomycetemcomitans, and Proteus strains [51–62]. Many of
these organisms are Gram-negative bacteria and the presence of 6-deoxy-talose in their LPS
and in the EPS from the Gram-positive B. longum 35624 suggests that specificmonosaccha-
rides can be shared in the surface associated polysaccharides of widely divergent bacteria. In
most cases, 6-deoxy-L-talose has been reported to beO-acetylated at position 2 and 4,
respectively.
In conclusion, we have identified a specific genetic locus associated with the biosynthesis of
a EPS in the human commensal B. longum 35624 strain. This EPS possesses a chemical struc-
ture that has not been previously described for other bifidobacterial strains. Future studies will
assess if the 35624 EPS has any immunoregulatory effects.
Materials and Methods
Bacterial culture conditions
Bifidobacteriawere routinely cultured in either de Man Rogosa and Sharpe medium (MRS;
Oxoid Ltd., Basingstoke, Hampshire, United Kingdom) supplemented with 0.05% cysteine-
HCl or reinforced clostridialmedium (RCM; Oxoid Ltd.). Bifidobacterial cultures were incu-
bated at 37°C under anaerobic conditions in a DonWhitley anaerobic Chamber. Modified
Man Rogosa and Sharpe agar plates, containing 3% glucose, were used to grow 35624 for EPS
extraction and purification.
Genome Sequencing and data assembly
Chromosomal DNA from bifidobacteriawas isolated as previously described [63]. The genome
sequence of 35624 was sequenced using a Roche 454 FLX Titanium instrument by the com-
mercial sequencing service providers Agencourt Bioscience (Beverly, MA) and Eurofins MWG
Operon (Germany) and then assembled, after which remaining gaps were closed using Sanger
Sequencing of PCR products. Sequence reads were initially assembled using Phred [64, 65],
Phrap (P. Green, University of Washington; http://www.phrap.org/), RepeatMasker (AFA.
Smit, R. Hubley, & P.Green; www.repeatmasker.org/) and the Staden software package [66].
Final assembly of the 35624 genome was verified using Newbler v 2.3 (http://454.com/
products/analysis-software/index.asp). The accession number for the 35624 genome sequence
is CP013673 (NCBI—http://www.ncbi.nlm.nih.gov/).
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General features prediction
Prediction of putative open reading frames (ORFs) was performed using PRODIGAL predic-
tion software (http://prodigal.ornl.gov/) and supported by BLASTX [67] alignments. Results of
Prodigal/BLASTXwere combined manually and a preliminary identification of ORFs was per-
formed on the basis of BLASTP analysis against a non-redundant protein database provided by
the National Centre for Biotechnology (http://www.ncbi.nlm.nih.gov/). Using the ORF finding
outputs and associated BLASTP results, Artemis [68] was employed for visualisation and man-
ual editing in order to verify, and if necessary, redefine the start of every predicted coding
region, or to remove or add coding regions. The assignment of protein function to predicted
coding regions was performedmanually. In addition, the individual members of the revised
gene/protein data set were searched against the protein family (Pfam) [69] and COG [70] data-
bases. Ribosomal RNA (rRNA) and transfer RNA (tRNA) genes were detected using RNAM-
MER (http://www.cbs.dtu.dk/services/RNAmmer/) and tRNA-scanSE (http://lowelab.ucsc.
edu/tRNAscan-SE/), respectively.
Phylogenetic analysis
The computation of a phylogenetic supertree was performed based on the alignment of a set of
orthologous proteins defined by the pan-genome computation. Each protein family was
aligned using CLUSTAL_W v1.83 [71]. Phylogenetic trees were computed using the maxi-
mum-likelihood in PhyML v3.0 [72] and concatenated; the resulting consensus tree was com-
puted using the Consensemodule from the Phylip package v3.69 using the majority rule
method (http://evolution.genetics.washington.edu/phylip.html).
35624 EPS isolation
The 35624 strain was cultured on MRS agar plates at 37°C under anaerobic conditions for 60
h. Cells were harvested using cell scrapers and resuspended for 2 h with constant rotary agita-
tion in PBS containing Ribonuclease A (1 μg/ml) and Deoxyribonuclease I (5 μg/ml Sigma,
St. Louis, MO, USA).Whole cells were removed by centrifugation for 30 min at 4°C and 20,000
x g (Sorval RC6 plus) and the supernatant was filtered through 0.45 μm syringe filters. The
EPS-containing solution was poured into 3 volumes of chilled ethanol, gently stirred for 30 sec-
onds and incubated at 4°C for 2 h. The precipitated EPS located at the surface of the ethanol
was removed with a spatula and resuspended in H20 under constant, yet gentle shaking for 2 h.
The solution was dialysed against H20 in a dialysis tubing (14 kDa, Sigma) at 4°C and conse-
quently applied 2 times on SPE C18 columns (Bakerbond) as indicated by the manufacturer
using a HyperSep-96TM vacuummanifold (Thermo Scientific). The flow-through fractionwas
collected and filtered through 0.45μm syringe filters. The solution was aseptically filled in glass
vials and freeze-dried (Virtis Genesis). Dried EPS was stored at -80°C until further analysis.
35624 EPS characterization and composition
Size exclusion chromatography was performedwith a PL aquagel-OHMIXED-H 8 μm column
(300 x 7.5 mm, Agilent,Waldbronn, Germany) at flow rate of 0.5 mL/min at room temperature
with 25 mM ammonium acetate (pH 8.5) and a refractive index detector. Dextran standards
(Sigma) with nominal masses (Mw) of 25, 150 and 1185 kDa were used for comparison.
Anion exchange chromatography was performedwith EconoPac-Q cartridge (Bio-Rad,
Vienna, Austria). The EPS was applied in 50 mm ammonium acetate and eluted with a NaCl
gradient. Fractions were analyzed for carbohydrate by the orcinol-sulfuric acid method.
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EPS was hydrolyzed with 4 M trifluoro acetic acid at 100°C for 4 h. The monosaccharides
were derivatizedwith anthranilic acid and analyzed by reversed phase HPLC using a 5 μm
Kinetex C18 core-shell column (Phenomenex, Torrens, CA) and an acetonitrile gradient in
either 0.2% 1-butylamin, 0.5% phosphoric acid, 1% tetrahydrofuran [73] or in 0.3% formic
acid buffered to pH 3.0 with ammonia in order to allow subsequent mass spectrometric verifi-
cation of peaks [74]. High-performance liquid chromatography of monosaccharides as 1-phe-
nyl-3-methyl-5-pyrazolone (PMP) derivatives was performed on a Hypersil ODS column as
described [75]. Gas chromatographic analysis of alditol acetates was performedwith a 60 m
OPTIMA1 1 MS Accent column with 0.25 mm inner diameter and 0.25 μm film thickness
(Macherey-Nagel, Düren, Germany) with mass spectrometric detection on a GC System
7820A with coupled to a MSD5975 (both Agilent, Waldbronn, Germany) [76].
For determination of the D/L configuration of Gal and Glc monosaccharides were reacted
with L-cysteinemethyl ester [37]. The dried sample was then derivatizedwith N-methyl-N-tri-
methylsilyltrifluoroacetamidecontaining 1% trimethylchlorosilane. The sugars were immedi-
ately analyzed on an Optima 1MS Accent analytical column (Macherey-Nagel, Germany, 60
m×0.25 mm i.d., 0.25 μm film thickness, 100% dimethylpolysiloxane stationary phase) and
detectedwith a 7200 GC-QTOFMS system (Agilent, Waldbronn, Germany) [77]. Notably,
compounds were chemically ionized using methane to give molecular ions such that peaks aris-
ing from hexoses, deoxyhexoses and uronic acids could be discriminated. The dominating ion
for hexoses was the penta-trimethylsilyl derivative associated with an m/z of 658.2931.
35624 EPS linkage analysis
Linkage analysis by gas chromatography with electron impact-mass spectrometry (GLC-MS)
was conducted after hydrolysis of EPS under the mildest conditions that provided solubility in
dimethyl sulfoxide, i.e. 50 mM trifluoroacetic acid at 80°C for 4 h. Permethylation was achieved
with sodium hydroxide / methyl iodide followed by hydrolysis, reduction with sodium boro-
deuteride and acetylation. The resulting partiallymethylated alditol acetates were separated on
a 60 m OPTIMA1 1 MS Accent column with 0.25 mm inner diameter and 0.25 μm film thick-
ness (Macherey-Nagel, Düren, Germany). Retention time standards were obtained by deriva-
tizing glucose or galactose with sub-stoichiometric amounts of methyl iodide, which worked
well for tetra- and tri-methyl ethers.
Partial hydrolysis and fragment analysis
EPS was hydrolyzed with 0.25 M TFA at 80° for various times with 4 h giving the best yield of
fragments of suitable size. The samples were purified for analysis with porous graphitic carbon
(PGC) cartridges (25 mg, Hypersep Hypercarb, Thermo Scientific,Waltham, MA) equilibri-
tated with 0.3% formic acid buffered to pH 3.0 with ammonia and eluted with 50% acetonitrile
in this buffer. The eluate was dried, redissolved and separated by PGCHPLC on a 100 x 0.32
mm column (Hypercarb, Thermo Scientific)with a 30 min gradient from 5 to 20% (apart from
sample application at 1% and column cleaning up to 50%) acetonitrile in the above formic
acid/formate buffer [78]. Detection of compounds was accomplished by electrospray ioniza-
tion-mass spectrometry (ESI-MS/MS) on a BrukerMaxis G4 Q-TOF mass spectrometer oper-
ated in the data dependent acquisition mode. Selected oligosaccharides obtained by preparative
HPLC on a 100 x 3 mm hypercarb column (Thermo Scientific) applying the conditions used
with the analytical column. Fractions containing relevant oligosaccharideswere pooled, dried
and permethylated as described above, however, with perdeutero-methyl iodide to allow dis-
crimination betweenmethyl groups and uronic acids. The permethylated oligosaccharides
were analyzed as [M+Na]+ ions by matrix assisted-time of flight-mass spectrometryusing
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2,5-dihydroxybenzoic acid as matrix and an Autoflex MALDI-TOF/TOF-MS (Bruker, Bremen,
Germany) in the positive reflectron or in LIFTmode.
Preparative isolation of fraction os211 was done by hydrophilic interaction HPLC on a
TSKgel Amide-80 column (Tosoh Bioscience, Griesheim, Germany) as recommended by the
supplier.
Nuclear magnetic resonance (NMR) experiments
NMR spectra of the polysaccharide and tetrasaccharide sample were obtained for solutions in
99.9% D2O (0.6 mL) at 338 K on a Bruker Avance III 600 instrument (600.2 MHz for 1H, 150.9
MHz for 13C) equipped with a BBFO broad-band inverse probe head and z-gradients using
standard Bruker NMR software TopSpin 3.0. 1H spectra were referenced using DSS as standard
(δ = 0); 13C spectra were referenced using 1,4-dioxane as external standard (δ = 67.40). In gen-
eral, sweep widths of 5000–6000 Hz for 1H and 32000–36000 Hz for 13C were used. 1H,
1H-COSY experiment were measured using the pulse program cosygpqf. 1H, 13C-HSQC spec-
tra were obtained using the pulse program hsqcedetgpwith 1024 x 64 k data points and 600
scans per t1-increment. The J value for the HSQC and HMBC experiments was 145 Hz for
one-bond couplings. Double-quantum filtered 1H,13C-HMBC experiments were recorded
using the pulse program hmbcgpndqf with 4096 x 64 data points, 520 scans per t1-increment,
and values for long range JX,H coupling of 11 and 5 Hz, respectively. The HSQC-TOCSY exper-
iment was performed using the pulse program hsqcdietgpsispwith 1024 x 128 data points and
260 scans per t1-increment. The TOCSY experiment was recorded using the program
mlevphpp with 1024 x 256 k data points and a mixing time of 120 ms. ROESY spectra were
measured using the pulse program roesyphpp.2, 2048 x 256 data points and a ROESY-spinlock
pulse of 0.5 sec. Data were processed using a squared sine-bell function and zero filling one
time in the f1 dimension.
6-deoxy-L-talose was synthesized as follows. Ethylthio β-L-fucopyranoside was prepared
according to literature and was converted into the 3,4-O-isopropylidene derivative at a yield of
93%.While epimerization using Mitsunobu conditions or triflate-displacement failed, oxida-
tion by 2-iodoxybenzoic acid (IBX) followed by selelective reduction of the intermediate
2-ulose proceeded smoothly and afforded the talo-product. Deprotection via hydrolysis of the
thioglycoside and cleavage of the 3,4-O-acetonide afforded the efficient production of 6-deoxy-
L-talose [74].
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S1 Fig. Genomemap of B. longum 35624. The location of the predicted exopolysaccharide
gene cluster is illustrated. Track 1:All open reading frames located on the forward strand.
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frames located on the forward strand and colour coded according to functional assignment.
Track 4: All open reading frames located on the reverse strand and colour coded according to
functional assignment. Track 5: All identified rRNA (indicated in orange) and tRNAs (indi-
cated in green). Track 6: G + C plot and Track 7: The G + C skew.
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